Ates I, Arikan MF, Altay M, Yilmaz FM, Yilmaz N, Berker D et al (2018) The effect of oxidative stress on the progression of Hashimotos thyroiditis
Wegovy, Injection, 0.25 mg/0.5 mL Wegovy, Injection, 0.5 mg/0.5 mL Wegovy, Injection, 1 mg/0.5 mL Wegovy, Injection, 1.7 mg/0.75 mL Wegovy, Injection, 2.4 mg/0.75 mL These commercially available doses, even with the +/- 10% dosage window, leave significant gaps that personalized compounding can fill
Sources KFF health tracking poll May 2024: The publics use and views of GLP-1 drugs GLP-1 global forecast JP Morgan obesity drugs research Novo Nordisk market trends US weight loss drug prices vs other countries MIT report on GLP-1s Fortune Magazine report on Ozempic and Wegovy Yahoo Finance Novo Nordisk A/S (NVO) CNBC soaring demand for Wegovy and Ozempic FAIR Health white paper on obesity and GLP-1 drugs JAMA research letter on risk of gastrointestinal adverse events with GLP-1 drugs University of Queenslands risks and benefits of Ozempic Business model reinvention GLP-1 trends & impact survey
In women with polycystic ovary syndrome (PCOS) and obesity, GLP-1 therapy has shown promise in improving reproductive hormone profiles, though this represents an off-label use with limited evidence
- Irritated and sensitive skin
The pills will be less expensive than Lillys Mounjaro or Zepbound pens
